VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

EORTC CLTF 2021 | Recent advances in understanding and managing CTCL

Robert Knobler • 15 Oct 2021
EORTC CLTF 2021
Cutaneous T-Cell Lymphoma Lymphoma Non-Hodgkin Lymphoma Rare Diseases Antibodies Mogamulizumab

Robert Knobler, MD, Medical University of Vienna, Vienna, Austria, comments on recent advances in the understanding and management of cutaneous T-cell lymphoma (CTCL). This interview took place at the EORTC Cutaneous Lymphoma Group 20-21 meeting in Marseille.

More from Robert Knobler

2:59
ECP for cutaneous lymphoma: current landscape & first prospective trial
Robert Knobler • 28 Sep 2018
1:05
Extracorporeal photopheresis for the treatment of CTCL
Robert Knobler • 15 Oct 2021

Related Videos

1:41
Key challenges of using the intestinal microbiome as a biomarker
Melody Smith
1:32
CAR T-cell therapy: the importance of LTFU
Graham Collins
2:55
CD19 CAR T-cell therapy for lymphoma
Michael Schmitt
1:23
Axicabtagene ciloleucel in the real-world: safety and efficacy
David Maloney
VJHemOnc VJHemOnc is intended for Healthcare Professionals only

By choosing to continue, you are confirming that you are a healthcare professional

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter

Subscribe now
The content of VJHemOnc is intended for healthcare professionals